Proof-of-Concept Gene Editing for the Murine Model of Inducible Arginase-1 Deficiency
about
Antitumor activity of EGFR-specific CAR T cells against non-small-cell lung cancer cells in vitro and in mice.Transplantation of Gene-Edited Hepatocyte-like Cells Modestly Improves Survival of Arginase-1-Deficient Mice.Novel Approaches for the Treatment of Familial Hypercholesterolemia: Current Status and Future Challenges
P2860
Proof-of-Concept Gene Editing for the Murine Model of Inducible Arginase-1 Deficiency
description
2017 nî lūn-bûn
@nan
2017 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Proof-of-Concept Gene Editing for the Murine Model of Inducible Arginase-1 Deficiency
@ast
Proof-of-Concept Gene Editing for the Murine Model of Inducible Arginase-1 Deficiency
@en
type
label
Proof-of-Concept Gene Editing for the Murine Model of Inducible Arginase-1 Deficiency
@ast
Proof-of-Concept Gene Editing for the Murine Model of Inducible Arginase-1 Deficiency
@en
prefLabel
Proof-of-Concept Gene Editing for the Murine Model of Inducible Arginase-1 Deficiency
@ast
Proof-of-Concept Gene Editing for the Murine Model of Inducible Arginase-1 Deficiency
@en
P2093
P2860
P1433
P1476
Proof-of-Concept Gene Editing for the Murine Model of Inducible Arginase-1 Deficiency
@en
P2093
Colin D Funk
Laurel L Ballantyne
Phillipe R Price
P2860
P2888
P356
10.1038/S41598-017-02927-2
P407
P50
P577
2017-05-31T00:00:00Z
P6179
1085634178